Search results
Results from the WOW.Com Content Network
Many of these cases have lead to class action lawsuits and proceedings by the Federal Trade Commision (FTC), resulting in a number of settlements worth millions — or even billions — of dollars ...
The following is a list of the 20 largest settlements reached between the United States Department of Justice and pharmaceutical companies from 2001 to 2013, ordered by the size of the total settlement. The settlement amount includes both the civil (False Claims Act) settlement and criminal fine.
The following are settlements reached with US authorities against pharmaceutical companies to resolve allegations of "off-label" promotion of drugs. Under the Federal Food, Drug, and Cosmetic Act, it is illegal for pharmaceutical companies to promote their products for uses not approved by the Food and Drug Administration (FDA), and corporations that market drugs for off-label indications may ...
The following is a list of the 21 largest civil settlements, reached between the United States Department of Justice and pharmaceutical companies from 2001 to 2017, ordered by the size of the total civil settlement. Some of these matters also resolved criminal fines and penalties, listed in parentheses, but these amounts are not considered when ...
In 2006, multinational telecommunications company Nortel agreed to pay $2.47 billion to two plaintiffs for accounting fraud, on the condition that the settlement contain no admission of wrongdoing ...
Negotiate the amount of the 1099 income before you finalize the settlement: Before you sign the settlement agreement, define whether or not the defendant will issue a Form 1099 or not. If they ...
false advertising, unfair business practices, breach of contract, fraud, deceit and/or misrepresentation: World Jewish Congress lawsuit against Swiss banks: retrieving deposits from dormant bank accounts: 2000
GSK on Wednesday said it agreed to settle another lawsuit in California alleging its discontinued heartburn drug Zantac caused cancer, as the British drugmaker sought to end costly litigation that ...